Quick Answer
REGENXBIO Inc. reported Operating Income Loss of -$161.20 million for the year ending 2025.
- REGENXBIO Inc. showed an increase of +30.9% in Operating Income Loss from 2024 to 2025.
- This data is from REGENXBIO Inc.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2014: -$1.70 million | Q1 2015: -$3.99 million | Q2 2015: -$6.30 million | Q3 2015: -$7.35 million | Q1 2016: -$11.25 million | Q2 2016: -$14.95 million | Q3 2016: -$18.67 million | Q1 2017: -$22.92 million | Q2 2017: -$15.06 million | Q3 2017: -$21.31 million | Q1 2018: $102.03 million | Q2 2018: $6.35 million | Q3 2018: -$22.73 million | Q1 2019: -$35.91 million | Q2 2019: -$36.87 million | Q3 2019: -$35.90 million | Q1 2020: -$37.70 million | Q2 2020: -$41.83 million | Q3 2020: $13.95 million | Q1 2021: -$44.04 million | Q2 2021: -$52.23 million | Q3 2021: -$57.35 million | Q1 2022: -$71.53 million | Q2 2022: -$62.53 million | Q3 2022: -$71.05 million | Q1 2023: -$66.16 million | Q2 2023: -$73.11 million | Q3 2023: -$64.96 million | Q1 2024: -$63.86 million | Q2 2024: -$56.04 million | Q3 2024: -$62.08 million | Q1 2025: $12.13 million | Q2 2025: -$63.28 million | Q3 2025: -$52.41 million.
- Over the full 13 years of available data (2013 to 2025), REGENXBIO Inc.'s Operating Income Loss has declined by 3,275.2%.
- Historical annual values: Fiscal year 2025: -$161.20 million | Fiscal year 2024: -$233.35 million | Fiscal year 2023: -$268.13 million | Fiscal year 2022: -$262.88 million | Fiscal year 2021: $159.98 million | Fiscal year 2020: -$119.23 million | Fiscal year 2019: -$149.00 million | Fiscal year 2018: $88.10 million | Fiscal year 2017: -$75.89 million | Fiscal year 2016: -$65.34 million | Fiscal year 2015: -$23.14 million | Fiscal year 2014: -$3.68 million | Fiscal year 2013: -$4.78 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: